Communications with Government
It is crucial for pharmacists to be involved when governments are making decisions that affect our profession and the health and safety of Canadians. CPhA is dedicated to ensuring that pharmacists’ voices are heard. We communicate with all levels of government on a regular basis, submitting position statements, offering support and presenting to senate committees on issues that are important to you.
Parliamentary Committee Briefs
February 2013
Speaking notes to the Senate Committee on Social Affairs, Science, and Technology
Offical transcript of the proceedings, February 27, 2013
RE: Off-label use of prescription drugs
October 2011
Submission to the Senate Committee on Social Affairs, Science, and Technology
RE: Reviewing the 2004 Health Accord
October 2011
Submission to the House of Commons Standing Committee on Health
RE: Study on chronic disease and aging
August 2011
Submission to the House of Commons Finance Committee
RE: Pre-budget consultations
October 2010
Opening remarks and written brief to the Senate Committee on Social Affairs, Science and Technology
RE: The role of pharmacists in the H1N1 pandemic and recommendations on how to improve future pandemic
August 2010
Submission to the House of Commons Standing Committee on Finance
RE: Pre-budget consultations
May 2008
Submission to the House of Commons Standing Committee on Health (en français)
RE: Review of the 10-Year Plan to Strengthen Health Care
February 2008
Presentation to House of Commons Standing Committee on Health (en français)
RE: Post-market surveillance
March 2007
Joint submission to the US Senate Sub-Committee
RE: Cross-border prescription drug trade
Communications with Government
March 2013
RE: Alberta Government Cuts to Generic Drug Prices
CPhA letter to Alberta Minister of Health re: Budget cuts to generic drug prices
March 2013
RE: Marihuana for Medical Purposes Regulations (MMPR) consultations
CPhA's response to proposed Marihuana for Medical Purposes Regulations
May 2012
RE: Cancellation of supplemental health benefits under the Interim Federal Health Program
Joint letter to Hon. Jason Kenney opposing cancellation of benefits
July 2011
RE: Medical Marihuana Consultations
Comments to Health Canada on the consultation document "Proposed
Improvements to Health Canada's Marihuana Medical Access Program"
December 2010
RE: Application of GST/HST to professional non-dispensing pharmacy services
CPhA's request to Canada Revenue Agency for clarification of the issue
Canada Revenue Agency's Response to CPhA
September 2010
RE: Pan-Canadian bulk purchasing arrangement for common drugs
First Ministers’ announcement
CPhA Response to Premiers (en français)
CPhA Position Paper (2005)
July 2010
RE: Mandatory census long form
Letter to Hon. Tony Clement
May 2010
RE: DIDFA
CPhA Response to the Government of Ontario’s proposed regulatory changes to the
Drug Interchangeability and Dispensing Fee Act
November 2006
RE: TDSPA
Submission to the Ontario Ministry of Long Term Care
Joint letter to Ontario Premier (CPhA, CACDS, CAPDM-Rx&D)
November 2006
RE: Cross-Border Prescription Drug Trade
Joint letter to Hon. Tony Clement (CPhA, OPA, CAPDM, BMC)
Joint Position Statement (CPhA, OPA, CAPDM, BMC)
November 2006
RE: Bill 41 – The Pharmaceutical Act
CPhA Letter of Support